Abstract HIV and substance use are inextricably intertwined. One-sixth of people living with HIV/AIDS (PLWHA) transition through the correctional system annually. There is paucity of evidence on the impact of substance use disorders on HIV treatment engagement among jail detainees. We examined correlates of HIV treatment in the largest sample of PLWHA transitioning through jail in 10 US sites from 2007 to 2011. Cocaine, alcohol, cannabis, and heroin were the most commonly used substances. Drug use severity was negatively and independently correlated with three outcomes just before incarceration: (1) having an HIV care provider (AOR = 0.28; 95 % CI 0.09-0.89); (2) being prescribed antiretroviral therapy (AOR = 0.12; 95 % CI 0.04-0.35) and (3) high levels ([95 %) of antiretroviral medication adherence (AOR = 0.18; 95 % CI 0.05-0.62).
Introduction
The interface between HIV and substance use is inextricably intertwined and is complicated by interactions with the criminal justice system (CJS) [1, 2] . Approximately one in six of the estimated 1.1 million HIV-infected individuals in the United States passes through the CJS annually. Most pass through jails where there is routine health assessment [3] . As such, jails represent an important opportunity not only to detect and treat HIV infection [4] , but also to screen for and treat substance use disorders (SUDs). Evidencebased treatments are now routinely available for the treatment of both conditions [2] , yet the availability of treatment for SUDs within criminal justice settings remains limited and the lack of treatment results in significant morbidity and mortality and recidivism to CJS [5] [6] [7] [8] [9] .
The CJS bears a considerable burden of individuals with SUDs, with up to 65 % of prison inmates meeting DSM-IV criteria for drug or alcohol abuse or dependence [10, 11] . Drug use profiles by people entering prison have not appreciably changed since 1997 [11] . SUDs have a profoundly negative impact on the health of people living with HIV/ AIDS (PLWHA) [2] . Not only are drug users less likely to be prescribed antiretroviral therapy (ART), but also, when they are, they are more likely to do so with advanced HIV infection and achieve less favorable HIV treatment outcomes compared to non-drug users [12, 13] .
In community settings, HIV-infected persons who actively use drugs and are not receiving evidence-based drug treatment have poor engagement in HIV care and adherence to ART [14] , including released prisoners [7, 15] . Alcohol use disorders similarly are associated with poor HIV treatment outcomes [16] especially for those within the CJS [17] . Provision of evidence-based treatment for SUDs, however, markedly improves HIV treatment outcomes [18] [19] [20] . Less than one-fifth of all PLWHA in the US have achieved viral suppression, far lower than the estimated 60 % needed to reduce the *56,000 new HIV infections annually-a number that has not changed appreciably in the past 15 years [21] . Understanding the types and severity of SUDs among PLWHA who enter jails provides insight into developing necessary strategies in order to better improve access to HIV care, prescription of ART and improve ART adherence, all of which are prerequisite to achieving viral suppression.
We therefore examined the correlates of three major components of the HIV treatment engagement cascade that are requisite for achieving HIV viral suppression in the largest sample of recruited HIV-infected jail detainees: (1) having a HIV care provider; (2) receiving ART and (3) achieving high levels of ART adherence (C95 %) among those prescribed it in the 30 days prior to incarceration. Moreover, because SUDs are chronic and relapsing conditions that figure prominently into comorbidity among jail detainees, we sought to describe the types of drugs used and their severity in order to provide insight into postrelease interventions necessary for this population.
Methods
Data for this cross-sectional study is from the baseline assessment of the Enhance Link initiative that enrolled HIV-infected adults aged 18 or older from 10 diverse jail settings in the US.
Study Settings
The 10 study sites in 9 states (CT, GA, IL, MA, NY, OH, PA, RI, SC) and entry criteria for each site [22] as well as the postrelease substance abuse treatment outcomes [23] have previously been described elsewhere. Subjects were enrolled if they were HIV-infected and provided written consent for study participation. Subjects in New York City (NYC) who received case management for a serious DSM-IV mental disorder were excluded and only women were recruited in Chicago. A total 1,270 baseline assessments resulted in 1,166 (91.8 %) subjects who knew their HIV diagnosis before incarceration and were included in the final analysis; 80 of the 1,270 total subjects who reported to be diagnosed with HIV during their index incarceration as well as 24 individuals with incomplete baseline data were excluded.
Dependent Variables
To assess the extent to which detainees were engaged in HIV care and treatment, we defined three dependent variables as the primary outcomes of interest: (1) Having an HIV care provider in the 30 days prior to incarceration; (2) Being prescribed ART in the 7 days prior to the index incarceration and (3) Being highly adherent (defined by self-report of having taken C95 % of prescribed ART) for the subset who received ART in the 7 days prior to incarceration.
Independent Variables and Behavioral Model for Vulnerable Populations
Independent variables were selected in accordance with the Behavioral Model for Vulnerable Populations. This model of health care utilization includes predisposing factors, enabling resources, and need factors as critical elements that influence health care utilization. In Fig. 1 , we adapt this model for this population as has been previously described for vulnerable populations [24] and HIV-infected jail detainees [25] .
According to the model, predisposing factors are the individuals' intrinsic characteristics that impact health care utilization. Represented in our study, they include age, gender, race, education, relationship status, sexual orientation, perception of health status, and the presence of a number of psychiatric and substance use disorders. Individuals' perception of their health status was dichotomized (good, very good, or excellent versus fair or poor). Enabling resources are those factors available to the individual by their community to facilitate access and health care utilization. These include having self-reported health insurance; food insecurity, defined as not having anything to eat for 2 days or more in the past 30 days and housing status with homelessness defined as self-identifying as homeless or having spent at least one night in public venues over the past month. Need factors assess the extent to which a person may need care and is often determined by the severity of the diseases, the individual's perception of their health and their priorities and needs for receiving care. These often include extent to which a person has multiple medical comorbidities, severity of drug or alcohol use, and severity of their psychiatric illnesses.
Types of drug use in the 30 days pre-incarceration was ascertained using the Addiction Severity Index (ASI) [26] that includes opioids (heroin, other opioids/analgesics/ painkillers), cocaine, cannabis, and amphetamines. Polysubstance use was defined as subjects using two or more substances per day (including alcohol). Pre-incarceration drug treatment was also reported from the ASI. Severity of substance use was determined by ASI Composite Scores [26] . The ASI composite scores were reported two ways: (1) continuous variables, ranging from 0 to 1 and (2) dichotomized composite scores using pre-specified cutoffs. Cut offs of 0.12, 0.15, and 0.22 for drug, alcohol, and psychiatric composite scores have been shown to confer high levels of sensitivity and specificity at (85 %, 86 %), (86 %, 80 %), and (90 %, 71 %), respectively, for DSM-IV diagnoses [25, 27] .
Statistical Analysis
All independent variables that assessed predisposing factors, enabling resources, and need factors as described by the Behavioral Model for Vulnerable Populations were assessed and the association between recent drug use and the aforementioned variables were studied. For continuous variables, the difference between the means was tested using independent-sample t test. For the categorical variables, the Pearson's Chi square test was used. Significance level was defined at 0.05.
Also, we used regression models to examine the correlations between the three major outcomes and drug use. We fitted univariate and multivariate regression models with unadjusted and adjusted odds ratio as the measures of strength. Age, gender, race, and ASI composite scores for drug, alcohol, and psychiatric illnesses plus any variable significant at the p B 0.10 in the univariate assessment were then entered into the multivariate logistic regression models to study their association with the three dependent outcomes while controlling for potential confounders. The significance of the overall model was evaluated using the log likelihood ratio test as well as Hosmer and Lemeshow goodness-of-fit test. Individual coefficients in the model were tested using Wald statistic for statistical significance. Multi-collinearity was evaluated between the covariates in the model using tolerance and Variance Inflation Factor (VIF). None of the covariates showed significant multicollinearity. All the analyses were performed with SPSS statistical software V.16 (SPSS Inc., Chicago IL).
Results
Demographic and drug use characteristics of the sample are presented in Table 1 . The mean age of the subjects was 42.8 years, mostly male (72.3 %), people of color (80.4 %) and heterosexual (78.0 %). Recent drug use over the 30-day pre-incarceration period was reported for cocaine (53 %), alcohol (51 %), cannabis (31.4 %), and heroin (26.8 %). Lifetime use of drug treatment was high with 70.6 % of all the detainees reported having received any treatment, while 55.7 % were treated by drug detoxification only. Of note, 19.6 % who received drug or alcohol treatment in the past 30 days reported concomitant recent substance use.
Using documented ASI composite score cutoffs for high levels of severity, 64.9, 36.9, and 52.3 % of subjects had ASI composite scores higher than the selected cut-offs for drug, alcohol, and psychiatric comorbidity respectively, indicating the group had the highest severity with underlying substance use and psychiatric illnesses.
The correlation between alcohol and drug use was examined using the corresponding ASI composite scores. Fig. 1 Conceptual model of health behaviors among the HIV-infected persons during the pre-incarceration periodadapted from Chen et al. [25] with permission S120 AIDS Behav (2013) 17:S118-S127 After controlling for potential covariates, lower drug use severity remained significant for all three primary outcomes. Table 2 presents the univariate and multivariate regression for correlates of having an HIV care provider in the last 30 days. Having health insurance, increased psychiatric severity and being seen by a physician for a non-HIV related condition were independently correlated with having a HIV provider, while increasing drug addiction severity, being female, black, homeless and having a selfperception of poor overall health status were associated with not having a HIV physician. With regard to the second outcome, receipt of ART just before incarceration (Table 3) , having health insurance, receiving treatment for a condition not related to HIV, and increasing psychiatric severity portended a 3.67-, 2.98-and 2.65-fold increased likelihood of receiving ART, respectively, while being Black, female, being younger, experiencing food insecurity, having self-perception of poor health status and having increasing levels of drug addiction severity was negatively associated with this outcome.
Independent correlates for achieving optimal levels of ART adherence, however, yielded different results aside from increasing drug addiction severity being associated with an 82 % reduced likelihood of achieving optimal adherence. For this outcome, none of the demographic, social or health utilization factors for other conditions were significant. Being employed and paid for work was associated with a two-fold increased likelihood of optimal adherence (Table 4) .
Discussion
Our findings illustrate that the prevalence of SUDs in the population of HIV-infected jail detainees is extremely high. Among all subjects, 72 % had used drugs in the 30 days before incarceration and is similar to findings from Arrestee Drug Abuse Monitoring (ADAM II) project, where 66 % reported any recent drug use, with the most commonly used substances being marijuana (35-58 %), cocaine (12-33 %), and heroin (3-22 %) [28, 29] . While most national surveys only measure recent use, our study extends this approach by also measuring addiction severity, which was particularly high within our sample with nearly two-thirds of subjects having scores exceeding the threshold for having DSM-IV criteria for SUDs. Moreover, 37 % and 52 % of inmates had composite scores above the cut-offs for alcohol dependence, and psychiatric illnesses, respectively. These figures document the syndemic nature of HIV, substance abuse, mental illness and its intersection with the criminal justice system.
Unlike the findings among arrestees from ADAM-II, HIV-infected jail detainees were more likely to use cocaine, heroin and alcohol, rather than marijuana. At least for those with opioid dependence and alcohol use disorders, there are a number of evidence-based treatments, primarily pharmacologically prescribed medication-assisted therapies, that would greatly benefit these individuals [2] . Specifically for opioid dependence, evidence-based treatments include methadone, buprenorphine and extended-release naltrexone (XR-NTX). In the case of alcohol dependence, naltrexone in either is oral or XR-NTX formulation is the preferred medication-assisted therapy, but acamprosate and disulfiram are also approved treatments [2] . In the case of cocaine abuse, some behavioral interventions, specifically cognitive behavioral therapy, have been shown to be effective, but there is no FDA-approved effective pharmacological therapy for cocaine use disorders [2, 17, 30] .
Central to this study is the negative contribution of active drug use and the level of severity on each of the three designated HIV treatment outcomes. To our knowledge, this is the first time that drug use severity has been associated with all three negative health consequences along the HIV continuum of care cascade. It would be reasonable to extrapolate that the significantly lower rates of treatment engagement, and specifically suboptimal adherence, would result in lower levels of viral suppression as well. In the US, as few as 19 % of all PLWHA are currently virally suppressed [21] . With one-sixth of all PLWHA transitioning through the CJS annually, it stands to reason that this population needs significantly better interventions to keep them fully engaged in care. Moreover, PLWHA who transition through the CJS have been documented to have high rates of HIV risk behaviors upon release [31] and in the absence of effective HIV risk reduction strategies such as consistent evidence-based drug treatment, condom use or syringe exchange programs, interventions that target viral suppression would greatly contribute to reducing HIV transmission and ultimately lower the *56,000 new infections that have remained unchanged for the past decade.
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in likelihood of having a HIV provider, a 19 % reduction in likelihood of receiving ART, and a 16 % reduction in achieving optimal ART adherence. Alcohol use severity, on the other hand, did not correlate with these outcomes aside from trending towards significance for ART adherence, but alcohol use disorders (AUD), per se, have been associated with a number of poor HIV treatment outcomes [16] , especially with CJS populations [17] . Unfortunately, only alcohol use severity and not the presence of an AUD was assessed in this study, but future jail-release programs should systematically assess them among PLWHA and link them with evidence-based alcohol relapse prevention treatments in order to improve retention in care and adherence with ART [32] .
Having health insurance was the strongest factor correlated with being engaged in HIV care and being prescribed ART. Similar findings have been found among the homeless [25] . Similarly, being female and black were independently and negatively associated with these two outcomes. Therefore interventions that focus on PLWHA transitioning from jail should be culturally and gender appropriate in order to reap the greatest benefits. Two comorbidities, individuals with high psychiatric severity and having been seen for a condition unrelated to HIV, were independently associated with having a HIV care provider and receiving ART. According to the Behavioral Model, these two factors would be consistent with need factors-having other conditions that require them to be engaged in care. Moreover, those with the highest psychiatric severity would also gain access to health insurance due to it being a disability and perhaps serve as a conduit to simultaneous HIV treatment. Although this is the largest study of its size, a few limitations exist. First, the study is cross-sectional and only associations rather than causality can be inferred. Second, most data are self-reported and may introduce information biases, including reporting and recall bias. Third, using the 30-day pre-incarceration period may introduce bias in two directions. Those whose lives have become more chaotic and result in incarceration may over-represent the drug use 
Conclusions
Recent active drug use and addiction severity is extremely high among PLWHA as they enter jail, and is associated with a number of demographic and social instability characteristics, suggesting the need for multidisciplinary and genderspecific interventions for PLWHA. Although HIV-infected jail detainees had a number of community-based interactions with drug treatment services, most of them had been ''detox'' and may not have included many evidence-based treatments.
The findings of increased drug use severity markedly reducing the engagement of PLWHA in the HIV treatment continuum of care suggests that evidence-based drug treatment interventions are urgently needed for this vulnerable and ''challenging'' population. 
